20/20 Biolabs (AIDX) vs Trinity Biotech (TRIB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Trinity Biotech is the larger company by market cap ($4.9 million vs $4.8 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AIDX | TRIB |
|---|---|---|
| Share price | $0.379 | $6.04 |
| Market cap | $4.84M | $4.91M |
| 1-day change | +10.33% | -10.91% |
| EPS (TTM) | $-0.75 | $-60.00 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $50.00 | $52.50 |
| 52-week low | $0.33 | $5.01 |
| Distance from 52-week high | -99.24% | -88.50% |
| Analyst consensus | none | — |
| Avg. price target upside | +1219.26% | — |
| Average volume | 90.86K | 21.66K |
| Shares outstanding | 12.77M | 813.13K |
| Employees | 4 | 287 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About 20/20 Biolabs
AIDX stock →20/20 Biolabs, Inc. develops and commercializes AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases.
Healthcare · Medical Devices · 4 employees
About Trinity Biotech
TRIB stock →Trinity Biotech plc, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Asia, Africa, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases, such as syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic measurement of haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes.
Healthcare · Medical Devices · 287 employees
AIDX vs TRIB FAQ
Which is bigger, 20/20 Biolabs or Trinity Biotech?
Trinity Biotech (TRIB) is larger, with a market capitalization of $4.91M compared with $4.84M for 20/20 Biolabs (AIDX).
Are 20/20 Biolabs and Trinity Biotech in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.